Elewski, B., A. Menter, J. Crowley, S. Tyring, Y. Zhao, S. Lowry, S. Rozzo, A. Mendelsohn, J. Parno, and K. Gordon. “Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S22, doi:10.25251/skin.2.supp.22.